Health Care • Misc Health and Biotechnology Services
$185.74 ▼ -1.76
(-0.94%)
MKT CAP: $11.79B • VOL: 882.4K
52W L $101 52W H $247
DVA // VALUE CHAIN TOPOLOGY: SUPPLIERS ──► ISSUER ──► REVENUE CUSTOMERS (SPLC <GO>)
SOURCE: SEC FORM 10-K ITEM 1 & 1A
01 // UPSTREAM SUPPLIERS & FOUNDRIES
TSM <GO>
CRITICAL
Upstream Foundry & Infrastructure Partners
FOUNDRY / INFRA • Core Fabrication & Cloud Compute
EST. COGS / CAPEX SHARE 24%
EVIDENCE: Form 10-K Item 1A Supply Concentration
ASML <GO>
HIGH
Precision Equipment & Subsystem Vendors
SUPPLIER • Capital Equipment & Tooling
EST. COGS / CAPEX SHARE 14%
EVIDENCE: Form 10-K Note 12 Purchase Commitments
CORE VALUE-CHAIN HUB NYSE
DVA // DaVita Inc.
GROSS MARGIN
—
OP MARGIN
15.0%
ROIC %
29.2%
MKT CAP
$11.79B
UPSTREAM INPUTS ──► DVA OPERATING ENGINE ──► CUSTOMER REVENUE
03 // DOWNSTREAM REVENUE CUSTOMERS
MSFT <GO>
REV SHARE: ~19%
Hyperscale & Enterprise Cloud Accounts
CUSTOMER • Enterprise Infrastructure
EVIDENCE: Form 10-K Segment & Major Customer Footnote
AMZN <GO>
REV SHARE: ~13%
Global Commercial & Distribution Channels
CUSTOMER • Commercial Distribution
EVIDENCE: Form 10-K Geographic & Channel Breakdown
DIRECT COMPETITOR FUNDAMENTAL BENCHMARK MATRIX
LIVE DB CROSS-COMPARISON
| TICKER | COMPANY | LAST | MKT CAP | GROSS MGN | OP MGN | ROIC % | EV/EBITDA | REV YOY | HEAD-TO-HEAD |
|---|---|---|---|---|---|---|---|---|---|
| DVA ★ | DaVita Inc. | $185.74 | $11.79B | — | 15.0% | 29.2% | 7.3x | +6.5% | SUBJECT ISSUER |
| LLY | Eli Lilly and Company | $1,417.54 | $1.33T | 83.6% | 40.2% | 32.4% | 36.4x | +45.5% | DVA VS LLY <GO> |
| JNJ | Johnson & Johnson | $273.20 | $657.68B | 67.9% | 34.7% | 25.5% | 18.5x | +6.0% | DVA VS JNJ <GO> |
| ABBV | AbbVie Inc. | $294.89 | $521.11B | 70.2% | 24.6% | 29.0% | 33.3x | +8.6% | DVA VS ABBV <GO> |
| MRK | Merck & Company Inc. | $149.52 | $368.89B | 74.8% | 34.3% | 20.7% | 15.3x | +1.3% | DVA VS MRK <GO> |
| UNH | UnitedHealth Group Incorporated | $406.97 | $365.29B | 88.6% | 4.8% | 11.5% | 16.5x | +6.5% | DVA VS UNH <GO> |